Considering that p63 is highly expressed in non‐neoplastic normal urothelial cells the data from us and others are consistent with a down‐regulation of p63 during tumour progression in a fraction of urothelial carcinomas. This evidence concerns the gene TP63 and urothelial carcinoma.